On June 19, 2014, Mast Therapeutics Inc (NYSEMKT:MSTX) announced that Howard C. Dittrich, M.D., F.A.C.C., has joined its Board of Directors. Dr. Dittrich, a cardiologist by training, has more than 20 years of experience in cardiac therapeutic research and clinical development. Mast Therapeutics Inc (NYSEMKT:MSTX) weekly performance is 7.81%. On last trading day company shares ended up $0.685. Analysts mean target price for the company is $1.00. Mast Therapeutics Inc (NYSEMKT:MSTX)distance from 50-day simple moving average (SMA50) is 12.67%.
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of PLX Technology, Inc. (NASDAQ:PLXT) for potential breaches of fiduciary duties in connection with the sale of the Company to Avago Technologies Ltd. for approximately $309 million. The Company’s stockholders will only receive $6.50 in cash for each share of PLX common stock they own. PLX Technology, Inc. (NASDAQ:PLXT) shares fell -0.15% in last trading session and ended the day on $6.47. PLXT Gross Margin is 56.50% and its return on assets is 9.20%. PLX Technology, Inc. (NASDAQ:PLXT) quarterly performance is 8.00%.
North American Palladium Ltd (USA) (NYSEMKT:PAL) released the final voting results of its 2013 Annual and Special Meeting of Shareholders (“AGM”) held on June 23, 2014 in Toronto, Ontario. North American Palladium Ltd (USA) (NYSEMKT:PAL) shares moved down -10.28% in last trading session and was closed at $0.317, while trading in range of $0.32 – $0.35. North American Palladium Ltd (USA) (NYSEMKT:PAL) year to date (YTD) performance is -50.77%.
IsoRay, Inc. (NYSE MKT: ISR), announced another milestone — the treatment of a brain tumor that had metastasized from esophageal cancer utilizing IsoRay’s liquid Cesium-131 (Cesitrex®) which recently was FDA cleared for internal radiation therapy. IsoRay, Inc. (NYSEMKT:ISR) ended the last trading day at $2.97. Company weekly volatility is calculated as 6.82% and price to cash ratio as 6.82. IsoRay, Inc. (NYSEMKT:ISR) showed a positive weekly performance of 20.73%.
ParkerVision, Inc. (NASDAQ:PRKR) was falling Tuesday after Ladenburg lowered its price target for the company. ParkerVision, Inc. (NASDAQ:PRKR) shares moved down -16.76% in last trading session and was closed at $1.54, while trading in range of $1.46 – $1.80. ParkerVision, Inc. (NASDAQ:PRKR)year to date (YTD) performance is 26.16%.